Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Director/PDMR/PCA Shareholding

28 Oct 2021 10:30

RNS Number : 5784Q
FDM Group (Holdings) plc
28 October 2021
 

28 October 2021

 

FDM GROUP (HOLDINGS) PLC

 

Director / PDMR / PCA Shareholding

 

FDM Group (Holdings) Plc ("FDM" or the "Company"), a global professional services provider with a focus on Information Technology, announces that on 26 October 2021, the following individuals, whose status is specified below, sold ordinary shares of £0.01 each in the capital of the Company ("Ordinary Shares") at a sale price of £11.83 per Ordinary Share.

 

Details of the number of Ordinary Shares sold by each individual are set out below:

 

Name of Individual

Position / Status

Number of Ordinary Shares sold

Roderick Flavell

 

Chief Executive Officer

983,466

Sheila Flavell

 

Chief Operating Officer

982,948

Andrew Brown

 

Chief Commercial Officer

539,000

Michael McLaren

 

Chief Financial Officer

10,000

Paula McLaren

Person Closely Associated with Michael McLaren (Chief Financial Officer)

53,079

 

Following these transactions, the shareholding of each of the individuals is as follows:

 

Name of Individual

Number of Ordinary Shares Held

% of Issued Share Capital of the Company

Roderick Flavell (Chief Executive Officer)

7,324,818

6.71%

Sheila Flavell (Chief Operating Officer)

 

7,320,956

6.70%

Andrew Brown (Chief Commercial Officer)

4,014,451

3.68%

Michael McLaren (Chief Financial Officer)

45,597

0.04%

Paula McLaren (Person Closely Associated with Michael McLaren, Chief Financial Officer)

424,216

0.39%

 

 

The notification below provides further information about these transactions.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

(a)

Name

(i) Roderick Flavell

(ii) Sheila Flavell

(iii) Andrew Brown

(iv) Michael McLaren

(v) Paula McLaren

 

2

Reason for the notification

 

(a)

Position/Status

(i) Chief Executive Officer

(ii) Chief Operating Officer

(iii) Chief Commercial Officer

(iv) Chief Financial Officer

(v) Person Closely Associated with Chief Financial Officer

 

(b)

Initial notification / Amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

FDM Group (Holdings) Plc

 

(b)

LEI

213800YR62D7GUZLMZ71

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of £0.01 each

 

 

ISIN: GB00BLWDVP51

(b)

Nature of the transaction

 

Sale of ordinary shares of £0.01 each

 

 

(c)

Price(s) and volume(s)

 

Name

(a) Number of Ordinary Shares sold

(b) Per Ordinary Share sale price

(i) Roderick Flavell

983,466

£11.83

(ii) Sheila Flavell

982,948

£11.83

(iii) Andrew Brown

539,000

£11.83

(iv)Michael McLaren10,000£11.83

(v) Paula McLaren

53,079

£11.83

 

(d)

Aggregated Information

- Aggregated Volume

- Price

N/A

 

 

(e)

Date of the Transaction

26 October 2021

 

 

(f)

Place of the Transaction

London Stock Exchange (XLON)

 

Name of authorised official of issuer responsible for making notification:

Mark Heather, Company Secretary, FDM Group (Holdings) Plc

 

 

Contacts

 

FDM Group (Holdings) plc

 

Rod Flavell, Chief Executive Officer

Tel: +44 (0)20 3056 8240 

Mike McLaren, Chief Financial Officer

 

Mark Heather, Company Secretary & Head of Investor Relations

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFESSAAEFSEIS
Date   Source Headline
8th Jun 20268:24 amRNSDisclosure of PSP Performance Condition Targets
3rd Jun 202611:01 amRNSAdmission to Trading
2nd Jun 20262:23 pmRNSDirector Shareholding & Block Listing Application
1st Jun 20267:00 amRNSTotal Voting Rights
21st May 20264:39 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
27th Apr 20263:51 pmRNSNotification of Transactions of Directors & PDMRs
21st Apr 20262:18 pmRNSDirector / PCA Shareholding
20th Apr 20267:00 amRNSDirector / PCA Shareholding
10th Apr 20264:34 pmRNS2026 Notice of Annual General Meeting
20th Mar 20265:18 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPreliminary Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
1st Dec 20259:17 amRNSTotal Voting Rights
13th Nov 202512:35 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
6th Nov 20254:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
17th Oct 20251:03 pmRNSDirector/PDMR Shareholding
4th Sep 20254:31 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202510:55 amRNSDirector/PDMR Shareholding
5th Aug 202510:03 amRNSHolding(s) in Company
1st Aug 20258:50 amRNSTotal Voting Rights
31st Jul 20255:27 pmRNSPDMR Shareholding
31st Jul 20253:45 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHalf-year Report
15th Jul 20255:07 pmRNSHolding(s) in Company
7th Jul 20259:48 amRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirectorate Change
6th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
23rd May 20255:07 pmRNSDirector/PCA Shareholding
20th May 20255:28 pmRNSResult of AGM
20th May 20257:00 amRNSAnnual General Meeting Statement
9th May 202511:10 amRNSDirector/PDMR Shareholding
8th May 20252:55 pmRNSDirector/PDMR Shareholding
1st May 20251:17 pmRNSDirector/PDMR Shareholding
23rd Apr 20259:51 amRNSDirector Shareholding
9th Apr 20254:32 pmRNSDirector/PDMR Shareholding
8th Apr 20255:42 pmRNSNotice of Annual General Meeting
1st Apr 20257:00 amRNSTotal Voting Rights
20th Mar 20254:31 pmRNSDirector / PCR Shareholding
19th Mar 20257:00 amRNSDirectorate Change
19th Mar 20257:00 amRNSPreliminary Announcement of Results FY2024
14th Mar 20254:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.